Amryt Pharma Plc (AMYT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AMYT Annual Balance Sheets →
A period-by-period view of the balance sheet from Amryt Pharma Plc to Dec 31 2020 helps clarify how Dec 31 2021's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2021)
0 0 0 (Dec 31 2020)
Assets
Cash And Cash Equivalents113.03
Cash & Short-term Investments113.00
Accounts receivable34.26
Notes Receivable, Current115.77
Other Current Assets52.02
Total Current Assets282.71
Equipment/Property/Plant Net7.42
Goodwill net56.69
Intangible Assets467.36
Other Assets, Noncurrent469.24
Total Assets816.06
Liabilities
Accounts Payable149.73
Longterm Borrowings93.40
Other Liabilities, Current56.34
Current Provisions7.55
Total Current Liabilities157.28
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent17.77
Noncurrent Provisions4.05
Total Liabilities459.40
Stockholders' Equity
Other Equity356.66
Common Stockholder's Equity356.66
Total Stockholder's Equity356.66
Liabilities & Stockholder's Equity816.06
4 historic quarters locked

Sign in to unlock the full Amryt Pharma Plc balance sheet history.

About Amryt Pharma Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001140361-22-016877

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.